Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FDA: little evidence to drop Chantix boxed warning

FDA: little evidence to drop Chantix boxed warning

Matthew Perrone · October 14, 2014 10:57 pm

New once-a-day pill for hepatitis C wins FDA OK

New once-a-day pill for hepatitis C wins FDA OK

Matthew Perrone · October 10, 2014 9:16 pm

Safety advocates seek stronger warnings on Chantix

Safety advocates seek stronger warnings on Chantix

Matthew Perrone · October 8, 2014 8:27 pm

Monsanto posts larger-than-expected 4Q loss

Monsanto posts larger-than-expected 4Q loss

Matthew Perrone · October 8, 2014 3:38 pm

Experimental drug provided to Dallas Ebola patient

Experimental drug provided to Dallas Ebola patient

Matthew Perrone · October 6, 2014 8:04 pm

Drugmaker submits harder-to-abuse Zohydro to FDA

Drugmaker submits harder-to-abuse Zohydro to FDA

Matthew Perrone · October 1, 2014 6:33 pm

New FDA label bolsters safety case for Chantix

New FDA label bolsters safety case for Chantix

Matthew Perrone · September 24, 2014 9:40 pm

Anti-addiction groups call for new FDA chief

Anti-addiction groups call for new FDA chief

Matthew Perrone · September 24, 2014 5:56 pm

FDA warns doctors to beware fake drug distributors

FDA warns doctors to beware fake drug distributors

Matthew Perrone · September 23, 2014 2:24 pm

Experts want restrictions on testosterone drug use

Experts want restrictions on testosterone drug use

Matthew Perrone · September 17, 2014 9:46 pm

Big cities take aim at prescription painkillers

Big cities take aim at prescription painkillers

Matthew Perrone · September 16, 2014 5:25 pm

FDA approves weight-loss drug Contrave

FDA approves weight-loss drug Contrave

Matthew Perrone · September 11, 2014 5:48 pm